Disclosure Statement: All authors are federal government employees and preparation of this manuscript was completely funded by the U.S. Government. Otherwise, no additional financial disclosures were reported by the authors of this paper.
Shift work and cancer screening: Do females who work alternative shifts undergo recommended cancer screening?
Article first published online: 30 NOV 2013
Published 2013 Wiley Periodicals, Inc.
American Journal of Industrial Medicine
Volume 57, Issue 3, pages 265–275, March 2014
How to Cite
Tsai, R. J., Luckhaupt, S. E., Sweeney, M. H. and Calvert, G. M. (2014), Shift work and cancer screening: Do females who work alternative shifts undergo recommended cancer screening?. Am. J. Ind. Med., 57: 265–275. doi: 10.1002/ajim.22285
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Institute for Occupational Safety and Health, or the National Center for Health Statistics.
- Issue published online: 2 FEB 2014
- Article first published online: 30 NOV 2013
- Manuscript Accepted: 11 NOV 2013
- U.S. Government
- shift work;
- cancer screening recommendations;
- breast cancer;
- cervical cancer;
- colorectal cancer
Alternative shift work is classified as a probable human carcinogen. Certain cancer screening tests reduce cancer mortality.
The 2010 National Health Interview Survey was used to examine associations between adherence to breast, cervical, and colon cancer screening recommendations and alternative shift work among female workers.
Workers on alternative shifts, compared to workers on daytime shifts, were more likely to be non-adherent to screening recommendations for breast (34% vs. 23%) and colorectal (55% vs. 48%) cancer (P < 0.05). Workers on alternative shifts in two industries (“Manufacturing” and “Accommodation/Food Services”) and three occupations (“Food Preparation/Serving,” “Personal Care Services,” and “Production”) were more likely to be non-adherent to screening recommendations for at least two cancers (P < 0.05).
The Affordable Care Act eliminates out-of-pocket screening expenses for these three cancers. Greater efforts are needed to promote this benefit, particularly among workers with demonstrated non-adherence. Am. J. Ind. Med. 57:265–275, 2014. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.